Matches in SemOpenAlex for { <https://semopenalex.org/work/W2423404104> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2423404104 endingPage "A479" @default.
- W2423404104 startingPage "A478" @default.
- W2423404104 abstract "To characterise UK Cancer Drug Fund (CDF) scoring of breast cancer drugs using the CDF prioritisation tool and to assess the final decisions made by the Chemotherapy Clinical Reference Group (CCRG) and the national CDF panel. The CDF decision summaries (available online at www.england.nhs.uk/ourwork/pe/cdf/cdf-drug-sum) record the formal decisions of the CCRG in relation to drugs and drug indications that are reviewed for inclusion on the national CDF list. We reviewed the individual scoring for each treatment in the criteria using the CDF prioritisation tool. Assessed criteria included: magnitude of survival benefit (progression free survival and overall survival), quality of life, toxicity compared with existing therapies, degree of unmet clinical need, strength of evidence and total score. Between April 2013 and May 2015, 15 decision summaries assessing 7 drugs for the treatment of breast cancer were reported by the CCRG. Of these summaries, 5 saw a positive overall decision and 10 were negative. The overall scoring of drugs varied considerably, with scores ranging from 1 to 13 and with just under half of drugs (7/15) receiving a score of 1 or no score at all. In contrast, the quality of evidence provided by manufacturers varied to a much lesser extent, with the majority of drugs receiving a score of “B” which, according to the scoring system, indicates one good-quality published Phase III randomised controlled trial. Understanding the way the UK CDF makes decisions on the provision of breast cancer treatments can help pharmaceutical companies prepare evidence in order to maximise market access. Identifying strengths and weaknesses in the scoring of previous submissions to the CDF can also optimise submissions to give patients with breast cancer the best chance of access to innovative medicines." @default.
- W2423404104 created "2016-06-24" @default.
- W2423404104 creator A5008260806 @default.
- W2423404104 creator A5042919845 @default.
- W2423404104 creator A5082498785 @default.
- W2423404104 date "2015-11-01" @default.
- W2423404104 modified "2023-09-28" @default.
- W2423404104 title "Analysis of Evaluations Made by the uk Cancer Drug Fund Panel of Breast Cancer Treatments in Relation to Overall Scores and Final Cdf Decisions" @default.
- W2423404104 doi "https://doi.org/10.1016/j.jval.2015.09.1293" @default.
- W2423404104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26532686" @default.
- W2423404104 hasPublicationYear "2015" @default.
- W2423404104 type Work @default.
- W2423404104 sameAs 2423404104 @default.
- W2423404104 citedByCount "0" @default.
- W2423404104 crossrefType "journal-article" @default.
- W2423404104 hasAuthorship W2423404104A5008260806 @default.
- W2423404104 hasAuthorship W2423404104A5042919845 @default.
- W2423404104 hasAuthorship W2423404104A5082498785 @default.
- W2423404104 hasBestOaLocation W24234041041 @default.
- W2423404104 hasConcept C121608353 @default.
- W2423404104 hasConcept C126322002 @default.
- W2423404104 hasConcept C143998085 @default.
- W2423404104 hasConcept C512399662 @default.
- W2423404104 hasConcept C530470458 @default.
- W2423404104 hasConcept C535046627 @default.
- W2423404104 hasConcept C71924100 @default.
- W2423404104 hasConceptScore W2423404104C121608353 @default.
- W2423404104 hasConceptScore W2423404104C126322002 @default.
- W2423404104 hasConceptScore W2423404104C143998085 @default.
- W2423404104 hasConceptScore W2423404104C512399662 @default.
- W2423404104 hasConceptScore W2423404104C530470458 @default.
- W2423404104 hasConceptScore W2423404104C535046627 @default.
- W2423404104 hasConceptScore W2423404104C71924100 @default.
- W2423404104 hasIssue "7" @default.
- W2423404104 hasLocation W24234041041 @default.
- W2423404104 hasOpenAccess W2423404104 @default.
- W2423404104 hasPrimaryLocation W24234041041 @default.
- W2423404104 hasRelatedWork W1595863544 @default.
- W2423404104 hasRelatedWork W2014447844 @default.
- W2423404104 hasRelatedWork W2090299372 @default.
- W2423404104 hasRelatedWork W2113427382 @default.
- W2423404104 hasRelatedWork W2224319365 @default.
- W2423404104 hasRelatedWork W2297592050 @default.
- W2423404104 hasRelatedWork W3130591221 @default.
- W2423404104 hasRelatedWork W3196332669 @default.
- W2423404104 hasRelatedWork W4286448049 @default.
- W2423404104 hasRelatedWork W4365129602 @default.
- W2423404104 hasVolume "18" @default.
- W2423404104 isParatext "false" @default.
- W2423404104 isRetracted "false" @default.
- W2423404104 magId "2423404104" @default.
- W2423404104 workType "article" @default.